Gapping up
In reaction to strong earnings/guidance: N/A
M&A news: VAL +28.1% (sto be acquired by Sherwin-Williams (SHW) for $113 per share), MRKT +6.2% (Markit (MRKT) and IHS (IHS) announce $13 bln merger of equals), HOT +4.6% (Starwood Hotels (HOT) and Marriott (MAR) revise merger), IHS +2.1% (Markit (MRKT) and IHS (IHS) announce $13 bln merger of equals; also reported earnings)
Other news: ADXS +8% (announces publication of survival results with advaxis HER2 targeted immunotherapy in canine osteosarcoma in Clinical Cancer Research ), RMTI +4.6% (announces China FDA accepts co's Triferic drug submission for commercialization in China), SGYP +2% (says the exchange agreements entered into on March 17 will reduce Notes outstanding by 50%), TTM +1.8% (Sensex +1.3% overnight), IBN +1.2% (Sensex +1.3% overnight), DDD +0.8% (cont strength), TI +0.9% (confirmed it is advanced negotiations on CEO's Marco Patuano resignation), HZNP+0.9% (announced Health Canada Notice of Compliance for RAVICTI), NKE+0.9% (positive Barrons article)
Analyst comments: FTNT +2.3% (initiated on the Conviction Buy List at Goldman ), TSLA +1.1% (upgraded to Buy from Hold at Argus), CYBR +0.9% (initiated with a Buy at Goldman)
In reaction to strong earnings/guidance: N/A
M&A news: VAL +28.1% (sto be acquired by Sherwin-Williams (SHW) for $113 per share), MRKT +6.2% (Markit (MRKT) and IHS (IHS) announce $13 bln merger of equals), HOT +4.6% (Starwood Hotels (HOT) and Marriott (MAR) revise merger), IHS +2.1% (Markit (MRKT) and IHS (IHS) announce $13 bln merger of equals; also reported earnings)
Other news: ADXS +8% (announces publication of survival results with advaxis HER2 targeted immunotherapy in canine osteosarcoma in Clinical Cancer Research ), RMTI +4.6% (announces China FDA accepts co's Triferic drug submission for commercialization in China), SGYP +2% (says the exchange agreements entered into on March 17 will reduce Notes outstanding by 50%), TTM +1.8% (Sensex +1.3% overnight), IBN +1.2% (Sensex +1.3% overnight), DDD +0.8% (cont strength), TI +0.9% (confirmed it is advanced negotiations on CEO's Marco Patuano resignation), HZNP+0.9% (announced Health Canada Notice of Compliance for RAVICTI), NKE+0.9% (positive Barrons article)
Analyst comments: FTNT +2.3% (initiated on the Conviction Buy List at Goldman ), TSLA +1.1% (upgraded to Buy from Hold at Argus), CYBR +0.9% (initiated with a Buy at Goldman)